Disprocynium24, a novel inhibitor of the extraneuronal monoamine transporter, has patent effects an the inactivation of circulating noradrenaline and adrenaline in conscious rat

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 354, Issue 3, 1996, Pages 287-294

  Eisenhofer, Graeme ^a,e   McCarty, Richard ^b   Pacak, Karel ^a   Russ, Hermann ^c   Schömig, Edgar ^d  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c Neurologische Psyckiatrische U   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Adrenaline kinetics; Catechol O methyltransferase; Extraneuronal transporter; Metanephrine kinetics; Monoamine uptake; Noradrenaline kinetics; Normetanephrine kinetics

Indexed keywords

1,1' DIISOPROPYL 2,4' CYANINE; ADRENALIN; DISPROCYNIUM 24; METADRENALIN; NORADRENALIN; NORMETADRENALIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CATECHOLAMINE METABOLISM; CONTROLLED STUDY; DRUG BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; RAT;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; CATECHOLAMINES; EPINEPHRINE; KINETICS; MALE; METABOLIC CLEARANCE RATE; METHOXYHYDROXYPHENYLGLYCOL; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0029813325     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Axelrod J (1971) The fate of noradrenaline in the sympathetic neurone. The Harvey Lectures 67:175-197
2. Chang PC, van Der Krogt JA, Van Brummelen P (1987) Demonstration of neuronal and extraneuronal uptake of circulating norepinephrinc in the forearm. Hypertension 9:647-653
3. Eisenhofer G, Finberg JPM (1994) Different metabolism of norepinephrinc and epinephrine by catechol-O-methyltransferase and monoamine oxidase in rats. J Pharmacol Exp Ther 268:1242-1251
4. Eisenhofer G, Goldstein, DS, Stull R, Keiser HR, Sunderland T, Murphy DL, Kopin IJ (1986) Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem 32:2030-2033
5. Eisenhofer G, Goldstein DS, Kopin IJ (1989) Plasma dihydroxyphenylglycol for estimation of noradrenaline neuronal re-uptake in the sympathetic nervous system in vivo. Clin Sci 76:171-181
6. Eisenhofer G, Fribcrg P, Pacak K, Golstein DS, Tsigos C, Quyyumi AA, Brunner HG, Lenders JWM (1995) Plasma metadrenalines: do they provide useful information about sympatho-adrenal function and catecholaminc metabolism. Clin Sci 88:533-542
7. Elser M, Jackman G, Bobik A, Kelleher D, Jennings G, Leonard P, Skews H, Korner P (1979) Determination of norepinephrine apparent release rate and clearance in humans. Life Sci 25: 1461-1470
8. Elser M, Jackman G, Leonard P, Skews H, Bobik A, Jennings G (1981a) The effect of propanolol on noradrenaline kinetics in patients with essential hypertension. Br J Clin Pharmacol 12:375-380
9. Elser M, Jackman G, Leonard P, Skews H, Bohik A, Korner P (1981b) Effect of norepinephrine uptake blockers on norepinephrine kinetics. Clin Phamacol Ther 29:12-20
10. 3H-(- -)-noradrenaline in the perfused rat heart. Naunyn-Schmiedeberg's Arch Pharmacol 303: 21-35
11. Friedgen B, Wölfel R, Russ H, Schömig E, Graefe K-H (1996) The role of extraneuronal membrane transport systems for the removal of extracellular catecholamines in the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 354:275-286
12. Goldstein DS, Eisenhofer G, Stull R, Folio CJ, Keiser HR, Kopin IJ (1988) Plasma dihydroxyphenylglycol and the intraneuronal dispostiion of norepinephrine in humans. J Clin Invest 81:213-220
13. Graefe K-H, Henseling M (1983) Neuronal and extraneuronal uptake and metabolism of catecholamines. Gen Pharmacol 14:27-33
14. Gründemann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H (1994) Drug excretion mediated by a new prototype of polyspecific transporter. Nature 372:549-552
15. Gryglewski R, Vane JR (1970) The inactivation of noradrenaline and isoprenaline in dogs. Br J Pharmacol 39:573-584
16. Halbrügge T, Friedgen B, Ludwig J, Graefe K-H (1993) Effects of catechol-O-methyltransferase inhibition on the plasma clearance of noradrenaline and the formation of 3,4-dihydroxyphenyl-glycol in the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 347:162-170
17. Iversen LL (1965) The uptake of catecholamines at high perfusion concentrations in the rat isolated heart: a novel catecholamine uptake process. Br J Pharmacol 25: 18-33
18. Lappe RW, Henry DP, Willis LR (1980) Mechanism of renal tubular secretion of norepinephrine in the rabbit. J Pharmacol Exp Ther 215:443-449
19. Lenders JWM, Eisenhofer G, Armando I, Keiser HR, Goldstein DS, Kopin IJ (1993) Determination of plasma metanephrines by liquid chromatography with electrochemical detection. Clin Chem 39:97-103
20. 3H-transmitter release elicited by nerve stimulation in the isolated nerve-muscle preparation of the cat nictitating membrane. Naunyn-Schmiedeberg's Arch Pharmacol 287:261-275
21. Marino V, de la Lande IS, Newlyn M, Parker DAS (1993) Evidence for uptake 2-mediated O-methylation of noradrenaline in the human amnion FL cell-line. Naunyn-Schmiedeberg's Arch Pharmacol 347:371-378
22. Pacholczyk T, Blakely RD, Amara SG (1991) Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350:350-354
23. Russ H, Engel W, Schömig E (1993a) Isocyanines and pseudo-isocyanines as a novel class of potent noradrenaline transport inhibitors: Synthesis, detection, and biological activity. J Med Chem 36:4208-4213
24. Russ H, Sonna J, Keppler K, Baunach S, Schömig E (1993b) Cyanine-related compounds: a novel class of potent inhibitors of extraneuronal noradrenaline transport. Naunyn-Schmiedeberg's Arch Pharmacol 348:458-465
25. 1-antagonistic properties of two cyanine-type inhibitors of extraneuronal monoamine transport. Naunyn-Schmiedeberg's Arch Pharmacol (in press)
26. 2 in the isolated rat heart by steroids, clonidine and methoxylated phenylethylamines. Eur J Pharmacol 20:329-340
27. Schömig E, Schönfeld C-L (1990) Extraneuronal noradrenaline transport (uptake2) in a human cell line (Caki-1 cells). Naunyn-Schmiedeberg's Arch Pharmacol 341:404-410
28. Schömig E, Babin-Ebell J. Russ H (1993) 1,1′-dicthy- 2.2′-cyanine (decynium22) potently inhibits the renal transport of organic cations. Naunyn-Schmiedeberg's Arch Pharmacol 347:379-383
29. Trendelenburg U (1988) The extraneuronal uptake and metabolism of catecholamines. In: Trendelenburg U, Weiner N (eds) Catecholamines I. Handbook of experimental pharmacology, vol 90. Springer, Berlin Heidelberg New York Tokyo. pp 279-319
30. Wallenstein S, Zucker CL, Fleiss JL (1980) Some statistical methods useful in circulation research. Circ Res 47:1-9
31. Zimlichman R, Goldstein DS, Eisenhofer G, Stull R, Keiser HR (1986) Comparison of noradrenaline and isoprenaline removal in the canine hindlimb and kidney. Clin Exp Pharmacol Physiol 13:777-781